American Diabetes Association

Novo Nordisk and Eli Lilly made notable advancements in the development of oral GLP-1 treatments for obesity, as announced at the American Diabetes Association (ADA) conference

Novo Nordisk and Eli Lilly Drive Breakthroughs in Oral GLP-1 Treatments for Obesity at ADA Conference

SG Tylor

Novo Nordisk and Eli Lilly showcased advancements in the development of oral GLP-1 treatments for Type II diabetes and obesity ...

Lilly Launches "Tap the Cap" with Adam Duvall, the American Diabetes Association, and other partners

Lilly Launches “Tap the Cap” with Adam Duvall, the American Diabetes Association, and other partners

SG Tylor

Source – Eli Lilly 20 June 2023, together with the American Diabetes Association (ADA) and professional baseball player Adam Duvall, ...

At the 83rd Scientific Sessions of the American Diabetes Association, Lilly will discuss fresh findings in the management of diabetes and obesity

SG Tylor

Source – Eli Lilly On 20 June 2023 at the American Diabetes Association’s (ADA) 83rd Scientific Sessions in San Diego ...